The minor duodenal papilla, which is the orifice of the accessory, or dorsal, pancreatic duct/Santorini duct, mostly accompanied by pancreatic tissue, is situated about 2 cm ventroproximal to the major duodenal papilla. The patency of the terminal accessory pancreatic duct (APD) is recognized in about half or more of cases, and is related to the degree of fibrosis. The APD is lined with simple columnar epithelium and encircled by a smooth muscle layer. It is still controversial whether or not these muscle tissues comprise a sphincter muscle. Pancreatic tissue was found in about 80% of cases in the minor papilla. Among these cases, pancreatic tissue was continuous and/or closely related to the proper pancreas in about 40% of cases, and might have the same exocrine and endocrine morphologies/functions, suggesting that it is a portion of the dorsal pancreas and not an ectopic one. Endocrine cell micronests are frequently found in the ductal wall/surrounding area of the terminal APD, and predominantly consist of somatostatin- and/or pancreatic-polypeptide-containing cells. In cases of pancreas divisum, inadequate pancreatic juice drainage from the minor papilla might occur, resulting in dorsal pancreatitis. In the minor papilla, all ductal tumors may occur, such as an intraductal papillary mucinous neoplasms and invasive ductal carcinoma, but carcinoid tumors are rare.

Keywords:
Accessory pancreatic duct, Endocrine cell micronests, Intraductal papillary mucinous neoplasm, Pancreas divisum, Pancreatic polypeptide
1.
Kamisawa T: Clinical significance of the minor duodenal papilla and accessory pancreatic duct. J Gastroenterol 2004;39:605–615.
2.
Stimec B, Alempijevic T, Micev M, Milicevic M, Ille T, Kovacevic N, Bulajic M: Relationship between papillary fibrosis and patency of the accessory pancreatic duct. Ann Anat 2005;187:99–103.
3.
Komatsu K: Pancreatographical and histopathological study of dilatation of the pancreatic ducts – with special references to cystic dilatations (in Japanese). Juntendo Med J 1973;19:250–269.
4.
Friersonk HF Jr: The gross anatomy and histology of the gallbladder, extrahepatic ducts, Vaterian system, and minor papilla. Am J Surg Pathol 1989:13:146–162.
5.
Kamisawa T (ed): Major and Minor Duodenal Papilla. Tokyo, Arc Medium, 2009.
6.
Suda K, Nobukawa B, Suzuki F, Fujii H, Matsumoto M, Matsumoto Y, Miyano T: Anomalous lesions of the pancreatic head and Vaterian system, related to their structures; in Suda K (ed): Pancreas – Pathological Practice and Research. Basel, Karger 2007, pp 12–24.
7.
Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A, Matsukawa M: Pancreas divisum in pancreaticobiliary maljunction. Hepatogastroenterology 2008;55:249–253.
8.
Suda K, Mogaki M: Histopathological and immuno-histochemical studies on the minor duodenal papilla (in Japanese). J Jpn Pancreat Soc 1990;4:511–517.
9.
Suda K, Mizuguchi K, Hoshino A: Differences of the ventral and dorsal anlagen of pancreas after fusion. Acta Pathol Jpn 1981;31:583–589.
10.
Suda K, Yuminamochi T, Ishii Y, Nakazawa K, Kawaoi A: Distribution of endocrine cells based on difference of the pancreatic anlage (in Japanese). Jpn J Clin Pathol 1987;35:809–812.
11.
Chatelain D, Vibert E, Yzet T, Geslin G, Bartoli E, Manaouil D, Delcenserie R, Brevet M, Dupas J-L, Regimbeau J-M: Groove pancreatitis and pancreatic heterotopia in the minor duodenal papilla. Pancreas 2005;30:e92–e95.
12.
Noda Y, Watanabe H, Iwafuchi M, Furuta K, Ishihara N, Satoh M, Ajioka Y: Carcinoids and endocrine cell micronests of the minor and major duodenal papillae. Their incidence and characteristics. Cancer 1992;70:1825–1833.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.